Emcure Pharmaceuticals Limited (BOM:544210)
1,609.15
-27.15 (-1.66%)
At close: Apr 28, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 304.90 billion as of April 28, 2026. Its market cap has increased by 62.96% in one year.
Market Cap
304.90B
Enterprise Value
317.78B
Revenue
88.50B
Ranking
n/a
PE Ratio
35.05
Stock Price
1,609.15
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 304.90B, an increase of 18.66%. That is a compound annual growth rate of 9.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 304.90B | 17.87% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 328.80B |
| GlaxoSmithKline Pharmaceuticals | 414.21B |
| AstraZeneca Pharma India | 214.40B |
| Abbott India | 540.85B |
| Granules India | 172.24B |
| Rubicon Research | 157.95B |
| Jubilant Pharmova | 151.24B |
| Caplin Point Laboratories | 134.04B |